Clinical Trial Update: Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating how photodynamic therapy for basal cell carcinoma alters the tumor immune microenvironment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Basal Cell Carcinoma | Phase 2 | Status: RECRUITING